Santos Ltd announces new CEO and $2.5 billion capital raising

Santos Ltd (ASX:STO) has bowed to shareholder and industry pressure, announcing the appointment of a new CEO and a capital raising.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An eagerly awaited Strategic Review from oil and gas producer Santos Ltd (ASX: STO) has hit the ASX boards this morning, revealing a number of crucial changes to the business.

Here're six key takeaways from the company's announcement:

  1. CEO David Knox is out and current Clough Limited CEO Kevin Gallagher is in (starting early 2016)
  2. A $3.5 billion reduction in net debt will take place via a number of initiatives
  3. $520 million will be generated from the sale of interest in the Kipper gas field, located off the coast of Victoria, to Mitsui E&P Australia Pty Ltd
  4. A $500 million private placement will be undertaken at a 15% premium to the last close price ($5.91) to China-based private equity firm, Hony Capital
  5. Santos will conduct a $2.5 billion fully underwritten accelerated pro-rata renounceable entitlement offer
  6. New dividend framework has been introduced

"The $3.5 billion of capital initiatives reinforce the Santos balance sheet and market a significant step towards restoring long term value for shareholders," Santos' Executive Chairman, Peter Coates, said. "We are very confident that the steps taken today will drive better returns for shareholders by strengthening the company's financial position and underscoring the value of its high quality and diverse asset base."

CEO appointment

Mr Gallagher will replace the outgoing David Knox in early 2016, subject to an agreement with Clough Limited. "He is ideally suited to lead Santos as we move from a focus on major strategic developments to delivering strong operational results in a continuing low oil price environment," Mr Coates said.

Previously, Mr Gallagher was an executive at Woodside Petroleum. "Kevin will bring fresh insight and a proven track record," Mr Coates added.

Mr Gallagher said, "I believe the Santos portfolio offers some truly exciting, word class opportunities, irrespective of the current global oil price environment."

Entitlement offer

Eligible retail shareholders will have the opportunity to take advantage of a 1-for-1.7 accelerated pro-rata renounceable entitlement offer. This means shareholders can buy one new share for every 1.7 they currently hold, at an offer price of $3.85 – a 34.9% discount to Santos' closing price. The retail offer will open at 9 am Tuesday 17 November and last until the end of the month. If you don't wish to participate, you can sell your right to buy new shares on the market.

"The Directors believe that it is in the interests of all shareholders to unequivocally strengthen the balance sheet at this time through this issue," Mr Coates said.

Dividend policy

In addition to the previously announced cuts to capital expenditure, Santos said it's committed to, "driving operational and capital efficiency" and has revised its dividend policy. Subject to business conditions, the board expects future payments to be a minimum of 40% of underlying net profit after tax. The final 2015 dividend is expected to be five cents per share.

Foolish Takeaway

Santos shareholders had likely prepared themselves for today's news, with media speculation suggesting the company would either have to raise capital, accept a takeover or sell key interests in some assets. It appears to have done two of those things, and although it has sold a stake to private equity, it's giving shareholders the right to participate in raising more capital.

With Santos shares frozen in a trading halt, investors can expect a lot of volatility in the weeks ahead once it resumes trading.

Motley Fool contributor Owen Raskiewicz has no position in any stocks mentioned. Owen welcomes your feedback on Google plus (see below), LinkedIn or you can follow him on Twitter @ASXinvest. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »